Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

Open Vet J. 2024; 14(5): 1199-1205


Kanamycin treated-ethylenediamine tetraacetic acid (EDTA)-dependent pseudothrombocytopenia in blood specimen of cats

Narissara Keawchana, Pirayu Rakwong, Pratthana Yongsakulchai.




Abstract
Cited by 0 Articles

Background:
Pseudothrombocytopenia is a commonly obtained false negative result when analyzing feline platelet count by automated machine. It is related to ethylenediamine tetra-acetic acid (EDTA), a widely utilized anticoagulant in blood collection tube, resulting in EDTA-dependent pseudothrombocytopenia (EDTA-PTCP).
Aim:
To investigate whether treated with kanamycin enhanced the quantity of platelet aggregations in feline blood specimens collected using EDTA-PTCP.
Methods:
Thirty-one blood samples were obtained using EDTA tubes. The complete blood count was analyzed using automated Mindray-BC-5000Vet. Both Manual cell counts and thin blood smears were performed to estimate the amount of RBC, WBC and platelets as well as to evaluate the severity scores of platelet clumping, respectively. Comparisons were made between those pre-treated and treated with kanamycin in EDTA tube.
Results:
There were significantly different mean platelet counts in the samples before and after they were treated with kanamycin, both on automated (156.6  76.4 vs 260.3  115.5; p < 0.001) and manual (168.5  92.1 vs 262.8  119.6; p < 0.001) readings, with a 95% confidence interval (CI) of 0.19 (0.022–0.365).
Conclusion:
This study suggests that in clinical laboratory practice, kanamycin should be added to feline blood specimens with EDTA-PTCP.

Key words: EDTA-PTCP, Feline, Kanamycin, Platelet clumping, Pseudothrombocytopenia






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.